Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Horak

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 10, 2014
Pathophysiology of anemia in chronic kidney diseases: A reviewJosef Zadrazil, Pavel Horak
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 30, 2022
Potential novel markers in IBD and CRC diagnostics. Are MMP-19 and RAGE promising candidates?Pavel Horak, Petr Suhaj, Radoslav Matej, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 11, 2025
The burden of multimorbidity in patients with systemic lupus erythematosus - single-centre analysisMarketa Dudkova, Martina Skacelova, Pavel Horak, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 3, 2017
Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damageMartina Skacelova, Zuzana Hermanova, Pavel Horak, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 15, 2024
Acute kidney injury due to gentamicin nephrotoxicity and specific miRNAs as biomarkersViktor Klementa, Nadezda Petejova, Pavel Horak, et al.
Frontiers in Immunology|January 2, 2025
High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritisAnna Petrackova, Pavel Horak, Jakub Savara, et al.
Haematologica|December 7, 2005
The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myelomaVlastimil Scudla, Marta Ordeltova, Jaroslav Bacovsky, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|June 12, 2013
Renal manifestations of rheumatic diseases. A reviewPavel Horak, Andrea Smrzova, Karel Krejci, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 16, 2013
Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patientAndrea Smrzova, Pavel Horak, Martina Skacelova, et al.
Current Rheumatology Reviews|September 9, 2014
Complement system in SLE as a target for antibodiesPavel Horak, Martina Skacelova, Josef Zadrazil, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 10, 2014
Pathophysiology of anemia in chronic kidney diseases: A reviewJosef Zadrazil, Pavel Horak
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 30, 2022
Potential novel markers in IBD and CRC diagnostics. Are MMP-19 and RAGE promising candidates?Pavel Horak, Petr Suhaj, Radoslav Matej, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 11, 2025
The burden of multimorbidity in patients with systemic lupus erythematosus - single-centre analysisMarketa Dudkova, Martina Skacelova, Pavel Horak, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 3, 2017
Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damageMartina Skacelova, Zuzana Hermanova, Pavel Horak, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 15, 2024
Acute kidney injury due to gentamicin nephrotoxicity and specific miRNAs as biomarkersViktor Klementa, Nadezda Petejova, Pavel Horak, et al.
Frontiers in Immunology|January 2, 2025
High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritisAnna Petrackova, Pavel Horak, Jakub Savara, et al.
Haematologica|December 7, 2005
The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myelomaVlastimil Scudla, Marta Ordeltova, Jaroslav Bacovsky, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|June 12, 2013
Renal manifestations of rheumatic diseases. A reviewPavel Horak, Andrea Smrzova, Karel Krejci, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 16, 2013
Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patientAndrea Smrzova, Pavel Horak, Martina Skacelova, et al.
Current Rheumatology Reviews|September 9, 2014
Complement system in SLE as a target for antibodiesPavel Horak, Martina Skacelova, Josef Zadrazil, et al.
Pageof 3